Portion Control Treatment for Obesity
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01451554|
Recruitment Status : Completed
First Posted : October 13, 2011
Results First Posted : November 28, 2011
Last Update Posted : November 28, 2011
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Behavioral: portion control plate Behavioral: Usual Care||Phase 2 Phase 3|
2-3 weeks prior to the patient's appointment with their primary care physician, the patient's medical record is reviewed to assess eligibility. If eligible, baseline patient characteristics are recorded, and a letter is sent to the patient informing them of the study and asking them to discuss this further with their primary care provider at their upcoming appointment.
At the primary care appointment, the patient is informed of the study and asked if they would like to participate. If the patient declines, their response is recorded. If the patient accepts, authorization is obtained and the patient is randomized by drawing a sealed envelope from either the male box or the female box, with both boxes being randomized. The envelope indicates either portion control plate or usual care. If the patient is randomized to usual care, Mayo Clinic pamphlets entitled "Lifestyle Changes for Healthy Weight" and "Exercise: Getting Started and Staying With It" are given to the patient. If the patient is randomized to the portion control plate, a 60 minute appointment with a dietician is scheduled. For pre-menopausal female patients who have not had a hysterectomy, a urine pregnancy test is performed to confirm that the patient is not pregnant prior to participation in the study.
At the dietitian appointment, the patient is given general information regarding portion size control and specific instructions on how to use a commercially calibrated portion control plate/bowl. The patient receives a handout containing instructions on how to use the plate/bowl along with food suggestions. The patient is instructed to use the plate for their largest meal of the day and encouraged to use the plate/bowl for all meals. The patient is also given a simple log-sheet to document the meals each day for which they used the plate/bowl.
The patients are then followed for 6 months. All patients are scheduled for weigh-ins at 3 months and 6 months. Patients in the portion control plate group are also contacted by phone or email (according to patient preference) at 1, 3, and 5 months by the dietitian to check-in and answer all questions. At completion of the study, patients in the portion control group are provided with a survey to assess their satisfaction with the intervention.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||65 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Portion Control for the Treatment of Obesity in the Primary Care Setting|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||June 2010|
|Actual Study Completion Date :||December 2010|
Active Comparator: Portion Control Intervention
Individuals will be given a portion control plate and dietary counseling
Behavioral: portion control plate
Individuals are provided with a portion control plate to use while eating and dietary counseling by dietician
Placebo Comparator: Usual Care
Provided with self-help booklets on diet and exercise.
Behavioral: Usual Care
Other Name: self-help booklets(exercise and lifestyle changes)
- Weight Change at 6 Months [ Time Frame: 6 months ]Weight change as a percentage of baseline at post 6 months.
- Weight Change at 3 Months [ Time Frame: 3 months ]Percentage change in weight at 3 months post study baseline
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01451554
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Jon O Ebbert, MD||Mayo Clinic|